Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Theravance Biopharma (TBPH) Interest Coverage Ratio (2016 - 2025)

Historic Interest Coverage Ratio for Theravance Biopharma (TBPH) over the last 10 years, with Q3 2025 value amounting to 11.27.

  • Theravance Biopharma's Interest Coverage Ratio rose 3451.03% to 11.27 in Q3 2025 from the same period last year, while for Sep 2025 it was 13.01, marking a year-over-year increase of 2528.58%. This contributed to the annual value of 18.44 for FY2024, which is 2266.49% up from last year.
  • Latest data reveals that Theravance Biopharma reported Interest Coverage Ratio of 11.27 as of Q3 2025, which was up 3451.03% from 4.11 recorded in Q2 2025.
  • Theravance Biopharma's Interest Coverage Ratio's 5-year high stood at 4.11 during Q2 2025, with a 5-year trough of 45.29 in Q1 2023.
  • Moreover, its 5-year median value for Interest Coverage Ratio was 17.2 (2024), whereas its average is 17.99.
  • Its Interest Coverage Ratio has fluctuated over the past 5 years, first tumbled by 93697.73% in 2021, then surged by 8314.61% in 2025.
  • Quarter analysis of 5 years shows Theravance Biopharma's Interest Coverage Ratio stood at 26.28 in 2021, then dropped by 20.59% to 31.69 in 2022, then surged by 68.4% to 10.02 in 2023, then crashed by 42.85% to 14.31 in 2024, then rose by 21.27% to 11.27 in 2025.
  • Its last three reported values are 11.27 in Q3 2025, 4.11 for Q2 2025, and 22.45 during Q1 2025.